Hillert J - Search Results

1

Swedish natalizumab (Tysabri) multiple sclerosis surveillance study.

Piehl F, Holmén C, Hillert J, Olsson T. Piehl F, et al. Among authors: hillert j. Neurol Sci. 2011 Jan;31 Suppl 3:289-93. doi: 10.1007/s10072-010-0345-y. Neurol Sci. 2011. PMID: 20556456

2

Conjugal multiple sclerosis: immunogenetic characterization and analysis of T- and B-cell reactivity to myelin proteins.

Fredrikson S, Michelsberg J, Hillert J, Wang Z, Sun JB, Olerup O, Olsson T, Link H. Fredrikson S, et al. Among authors: hillert j. Neurology. 1992 Mar;42(3 Pt 1):577-82. doi: 10.1212/wnl.42.3.577. Neurology. 1992. PMID: 1372398

3

Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis.

Olsson T, Sun J, Hillert J, Höjeberg B, Ekre HP, Andersson G, Olerup O, Link H. Olsson T, et al. Among authors: hillert j. Eur J Immunol. 1992 Apr;22(4):1083-7. doi: 10.1002/eji.1830220431. Eur J Immunol. 1992. PMID: 1372558

4

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Möller E, Carlsson B, Wallin J. Olerup O, et al. Among authors: hillert j. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7113-7. doi: 10.1073/pnas.86.18.7113. Proc Natl Acad Sci U S A. 1989. PMID: 2571150 Free PMC article.

5

Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development.

Fiten P, Vandenbroeck K, Dubois B, Van Coillie E, Nelissen I, Van Damme J, Ligers A, Hillert J, Andersson M, Olsson T, Opdenakker G. Fiten P, et al. Among authors: hillert j. J Neuroimmunol. 1999 Mar 1;95(1-2):195-201. doi: 10.1016/s0165-5728(99)00007-7. J Neuroimmunol. 1999. PMID: 10229131

6

Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis.

Nelissen I, Vandenbroeck K, Fiten P, Hillert J, Olsson T, Marrosu MG, Opdenakker G. Nelissen I, et al. Among authors: hillert j. J Neuroimmunol. 2000 Jun 1;105(1):58-63. doi: 10.1016/s0165-5728(00)00189-2. J Neuroimmunol. 2000. PMID: 10713364

7

PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia.

Nelissen I, Fiten P, Vandenbroeck K, Hillert J, Olsson T, Marrosu MG, Opdenakker G. Nelissen I, et al. Among authors: hillert j. J Neuroimmunol. 2000 Aug 1;108(1-2):153-9. doi: 10.1016/s0165-5728(00)00293-9. J Neuroimmunol. 2000. PMID: 10900349

8

HLA-DR15 is associated with lower age at onset in multiple sclerosis.

Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. Masterman T, et al. Among authors: hillert j. Ann Neurol. 2000 Aug;48(2):211-9. Ann Neurol. 2000. PMID: 10939572

9

Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci.

Xu C, Dai Y, Lorentzen JC, Dahlman I, Olsson T, Hillert J. Xu C, et al. Among authors: hillert j. Eur J Hum Genet. 2001 Jun;9(6):458-63. doi: 10.1038/sj.ejhg.5200653. Eur J Hum Genet. 2001. PMID: 11436128

10

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.

Killestein J, Olsson T, Wallström E, Svenningsson A, Khademi M, Blumhardt LD, Fagius J, Hillert J, Landtblom AM, Edenius C, Arfors L, Barkhof F, Polman CH. Killestein J, et al. Among authors: hillert j. Ann Neurol. 2002 Apr;51(4):467-74. doi: 10.1002/ana.10146. Ann Neurol. 2002. PMID: 11921052 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters